Concepedia

Publication | Open Access

Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C

22

Citations

29

References

2017

Year

Abstract

DAAs with or without IFN and RBV in the standard recommended 12 or 24-week treatment regimens are effective, well tolerated, and may be safely extended to elderly patients infected with chronic hepatitis C.

References

YearCitations

Page 1